Viridian Therapeutics, Inc. (VRDN)

$ 0.00
   
  • Closing Price Chg:
    $0.22
  • 52 Week High: $25.71
  • 52 Week Low: $10.56
  • Currency: US Dollars
  • Shares Issued: 30.60m
  • Volume: 0
  • RiskGrade: 566
  • Beta: 0.02

Financial Analysis

Select chart: EPS | Revenue

Key Fundamentals

Fundamentals data is not available for this company.

Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 0.20 (381.73) (377.38)¢ n/a n/a n/a n/a 0.0%
31-Dec-26 46.90 (394.97) (413.15)¢ n/a n/a n/a n/a 0.0%
31-Dec-27 252.58 (200.04) (188.37)¢ n/a n/a n/a n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

VRDN Market Data

Currency US Dollars
Share Price $ 18.02
Closing Price Change $ 0.22
% Change 0.00 %
52 Week High $25.71
52 Week Low $10.56
Volume 0
Shares Issued 30.60m
Beta 0.02
RiskGrade 566

What The Brokers Say

Strong Buy 7
Buy 7
Neutral 4
Sell 0
Strong Sell 0
Total 18
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for --2025

Time Volume / Share Price
0 @ $0.00

Top of Page